Letter On State Medicaid Coverage For People With HCV & SUD

On January 24, 2024, the Departments of Justice (DOJ) and Health and Human Services (HHS) issued a joint letter to state Medicaid administrators regarding state Medicaid coverage for people who have both Hepatitis C (HCV) and substance use disorder (SUD) to access life-saving HCV medications called direct-acting antivirals (DAAs). The letter emphasizes that the Americans with Disabilities Act (ADA) requires that states, in administering their Medicaid programs, provide individuals with disabilities, including addiction disorder, equal opportunity to participate in and benefit from a state’s Medicaid program . . .